Walgreens EBITDA Margin 2010-2024 | WBA
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Walgreens (WBA) over the last 10 years. The current EBITDA margin for Walgreens as of February 29, 2024 is .
| Walgreens EBITDA Margin Historical Data |
| Date |
TTM Revenue |
TTM EBITDA |
EBITDA Margin |
| 2024-02-29 |
$144.60B |
$-11.46B |
-7.92% |
| 2023-11-30 |
$142.41B |
$1.85B |
1.30% |
| 2023-08-31 |
$139.08B |
$-4.37B |
-3.14% |
| 2023-05-31 |
$136.11B |
$-4.84B |
-3.56% |
| 2023-02-28 |
$133.29B |
$-4.73B |
-3.55% |
| 2022-11-30 |
$132.18B |
$-3.69B |
-2.79% |
| 2022-08-31 |
$132.70B |
$3.80B |
2.86% |
| 2022-05-31 |
$134.52B |
$5.53B |
4.11% |
| 2022-02-28 |
$135.95B |
$6.98B |
5.14% |
| 2021-11-30 |
$134.97B |
$6.49B |
4.81% |
| 2021-08-31 |
$132.51B |
$3.18B |
2.40% |
| 2021-05-31 |
$124.19B |
$2.74B |
2.21% |
| 2021-02-28 |
$120.52B |
$0.04B |
0.03% |
| 2020-11-30 |
$119.08B |
$0.31B |
0.26% |
| 2020-08-31 |
$121.98B |
$3.25B |
2.66% |
| 2020-05-31 |
$113.20B |
$3.43B |
3.03% |
| 2020-02-29 |
$117.43B |
$6.10B |
5.19% |
| 2019-11-30 |
$120.62B |
$6.54B |
5.42% |
| 2019-08-31 |
$120.07B |
$6.97B |
5.80% |
| 2019-05-31 |
$136.35B |
$7.65B |
5.61% |
| 2019-02-28 |
$136.10B |
$8.04B |
5.90% |
| 2018-11-30 |
$134.59B |
$8.56B |
6.36% |
| 2018-08-31 |
$131.54B |
$8.25B |
6.27% |
| 2018-05-31 |
$128.24B |
$7.78B |
6.07% |
| 2018-02-28 |
$124.03B |
$7.70B |
6.21% |
| 2017-11-30 |
$120.45B |
$7.01B |
5.82% |
| 2017-08-31 |
$118.21B |
$7.27B |
6.15% |
| 2017-05-31 |
$116.70B |
$7.45B |
6.38% |
| 2017-02-28 |
$116.08B |
$7.42B |
6.39% |
| 2016-11-30 |
$116.82B |
$7.79B |
6.67% |
| 2016-08-31 |
$117.35B |
$7.76B |
6.61% |
| 2016-05-31 |
$117.24B |
$7.45B |
6.35% |
| 2016-02-29 |
$116.53B |
$7.31B |
6.27% |
| 2015-11-30 |
$112.92B |
$6.99B |
6.19% |
| 2015-08-31 |
$103.44B |
$6.73B |
6.50% |
| 2015-05-31 |
$93.98B |
$6.95B |
7.40% |
| 2015-02-28 |
$84.59B |
$6.61B |
7.81% |
| 2014-11-30 |
$77.62B |
$6.31B |
8.13% |
| 2014-08-31 |
$76.39B |
$6.13B |
8.02% |
| 2014-05-31 |
$75.28B |
$6.37B |
8.46% |
| 2014-02-28 |
$74.19B |
$6.31B |
8.51% |
| 2013-11-30 |
$73.23B |
$6.26B |
8.54% |
| 2013-08-31 |
$72.22B |
$5.87B |
8.13% |
| 2013-05-31 |
$71.35B |
$4.99B |
6.99% |
| 2013-02-28 |
$70.79B |
$4.71B |
6.66% |
| 2012-11-30 |
$70.79B |
$4.48B |
6.32% |
| 2012-08-31 |
$71.63B |
$4.63B |
6.46% |
| 2012-05-31 |
$72.53B |
$5.29B |
7.29% |
| 2012-02-29 |
$73.15B |
$5.34B |
7.30% |
| 2011-11-30 |
$73.00B |
$5.41B |
7.42% |
| 2011-08-31 |
$72.18B |
$5.45B |
7.55% |
| 2011-05-31 |
$71.09B |
$4.91B |
6.90% |
| 2011-02-28 |
$69.92B |
$4.78B |
6.83% |
| 2010-11-30 |
$68.40B |
$4.65B |
6.80% |
| 2010-08-31 |
$67.42B |
$4.49B |
6.66% |
| 2010-05-31 |
$66.25B |
$4.42B |
6.67% |
| 2010-02-28 |
$65.26B |
$4.43B |
6.79% |
| 2009-11-30 |
$64.75B |
$4.37B |
6.75% |
| Sector |
Industry |
Market Cap |
Revenue |
| Retail/Wholesale |
Retail - Drug Stores |
$15.572B |
$139.081B |
|
Walgreens Boots Alliance, Inc. operates as a retail drugstore chain. The Company sells prescription and non-prescription drugs, as well as general merchandise products, including household items, convenience and fresh foods, personal care, beauty care, photofinishing and candy. Its pharmacy, health and wellness services include retail, specialty, infusion and respiratory services, mail service and convenient care clinics. The Company offers its products and services through drugstores, as well as through mail, by telephone and online. Walgreens Boots Alliance, Inc., is based in Deerfield, Illinois.
|
